Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001415889-24-029979·PALVELLA THERAPEUTICS, INC.
Schedule 13G ownership disclosure
Palvella Therapeutics Inc
Common Stock, $0.001 par value per share · CUSIP: 697947109
Event date: 2024-12-13
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Samsara BioCapital, L.P.
Shares: 679,486.00 · Class: 6.1%
- Samsara BioCapital GP, LLC
Shares: 679,486.00 · Class: 6.1%
- Srinivas Akkaraju
Shares: 679,486.00 · Class: 6.1%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001415889-24-029979
- Form type
- SCHEDULE 13G
- Filer
- PALVELLA THERAPEUTICS, INC.
- CIK
- CIK 1583648
- Filed
- Dec 20, 2024
- Reporting period
- Dec 13, 2024
- Description
- Schedule 13G beneficial ownership